TherapeuticsMD Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2010
Net Income	-10.28	112	-172.42	-183.52	-176.15	Upgrade
Depreciation & Amortization	0.92	1.19	0.74	4.07	1.39	Upgrade
Share-Based Compensation	1.27	11.57	18.13	10.68	10.68	Upgrade
Other Operating Activities	-40.06	-128.84	10.86	9.31	-1.65	Upgrade
Operating Cash Flow	-48.14	-4.08	-142.69	-159.47	-165.72	Upgrade
Capital Expenditures	0	0	-0.03	-0.21	-2.45	Upgrade
Other Investing Activities	-	223.48	-2.19	-1.39	-21.44	Upgrade
Investing Cash Flow	0	223.48	-2.22	-1.6	-23.89	Upgrade
Share Issuance / Repurchase	3.15	2.47	184.67	31.98	77.14	Upgrade
Debt Issued / Paid	0	-221.05	-55.12	48.75	111.69	Upgrade
Other Financing Activities	-	-16.62	-	-	-	Upgrade
Financing Cash Flow	3.15	-235.21	129.55	80.73	188.83	Upgrade
Net Cash Flow	-44.99	-15.81	-15.36	-80.34	-0.78	Upgrade
Free Cash Flow	-48.14	-4.08	-142.73	-159.68	-168.17	Upgrade
Free Cash Flow Margin	-3697.47%	-5.83%	-5547.10%	-246.14%	-338.73%	Upgrade
Free Cash Flow Per Share	-4.61	-0.45	-17.93	-28.96	-34.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).